Dr. Hefty received Phase II CoBRE award

Dr. Scott Hefty, Professor, Department of Molecular Biosciences, has been awarded a Phase II Center of Biomedical Research Excellence (CoBRE) award, "Chemcal Biology of Infectious Disease".  This $11,348,826 grant is five years of research funding with the immediate short term goal of the CBID is to provide the necessary mentor support and infrastructure to ensure the success of junior investigators in acquiring NIH funding. The long term goal is to create a center that encourages basic research scientists to discover Chemical Biology of Infectious Disease and solution.